AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.260
-0.010 (-0.79%)
Dec 20, 2024, 4:00 PM EST - Market closed
AN2 Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for AN2 Therapeutics stock have an average target of 3.50, with a low estimate of 2.00 and a high estimate of 5.00. The average target predicts an increase of 177.78% from the current stock price of 1.26.
Analyst Consensus: Hold
* Price targets were last updated on Nov 19, 2024.
Analyst Ratings
The average analyst rating for ANTX stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 2 | 2 | 2 | 2 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 5 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JMP Securities | JMP Securities | Buy Reiterates $5 | Buy | Reiterates | $5 | +296.83% | Nov 19, 2024 |
TD Cowen | TD Cowen | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 18, 2024 |
JMP Securities | JMP Securities | Buy Maintains $6 → $3 | Buy | Maintains | $6 → $3 | +138.10% | Aug 9, 2024 |
Leerink Partners | Leerink Partners | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Jul 3, 2024 |
Evercore ISI Group | Evercore ISI Group | Hold Maintains $7 → $2 | Hold | Maintains | $7 → $2 | +58.73% | May 16, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.75
from -2.74
EPS Next Year
-1.09
from -1.75
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | n/a | n/a | 76.3M | |||
Avg | n/a | n/a | 37.1M | |||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -1.77 | -0.91 | -1.01 | |||
Avg | -1.75 | -1.09 | -1.07 | |||
Low | -1.71 | -1.22 | -1.08 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.